Hardy Alexander has filed 16 insider transactions across 1 company since December 2023.
Most recent transaction: a tax payment of 4252 shares of BIOMARIN PHARMACEUTICAL INC ($BMRN) on March 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | F | Common Stock | 4252 | $56.05 | 214,635.0000 | 196,893,000 | 1.94% | 0.00% |
| March 16, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Common Stock | 62440 | $0.00 | 218,887.0000 | 196,893,000 | 39.91% | 0.03% |
| March 16, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Stock Option (Right to Buy Common Stock) | 89200 | $0.00 | 89,200.0000 | 196,893,000 | 9999.99% | 0.05% |
| March 13, 2026 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | F | Common Stock | 2941 | $58.51 | 156,447.0000 | 196,893,000 | 1.85% | 0.00% |
| Dec. 1, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | F | Common Stock | 16570 | $55.03 | 159,388.0000 | 196,893,000 | 9.42% | 0.01% |
| April 30, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Common Stock | 375 | $54.14 | 175,958.0000 | 196,708,000 | 0.21% | 0.00% |
| March 14, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | F | Common Stock | 2933 | $69.44 | 131,223.0000 | 196,708,000 | 2.19% | 0.00% |
| March 17, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Common Stock | 44360 | $0.00 | 175,583.0000 | 196,708,000 | 33.81% | 0.02% |
| March 17, 2025 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Stock Option (Right to Buy Common Stock) | 61750 | $0.00 | 61,750.0000 | 196,708,000 | 9999.99% | 0.03% |
| Oct. 31, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Common Stock | 300 | $56.01 | 148,451.0000 | 197,147,000 | 0.20% | 0.00% |
| Nov. 29, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | F | Common Stock | 14295 | $66.03 | 134,156.0000 | 197,147,000 | 9.63% | 0.01% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Stock Option (Right to Buy Common Stock) | 44050 | $0.00 | 44,050.0000 | 191,595,000 | 9999.99% | 0.02% |
| March 15, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Common Stock | 32780 | $0.00 | 148,151.0000 | 191,595,000 | 28.41% | 0.02% |
| Dec. 1, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Common Stock | 68039 | $0.00 | 68,039.0000 | 188,963,000 | 9999.99% | 0.04% |
| Dec. 1, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Common Stock | 47332 | $0.00 | 115,371.0000 | 188,963,000 | 69.57% | 0.03% |
| Dec. 1, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | Hardy Alexander | Chief Executive Officer | A | Stock Option (Right to Buy Common Stock) | 150529 | $0.00 | 150,529.0000 | 188,963,000 | 9999.99% | 0.08% |